Healthcare provider profile · identity verified

Anne M Jaeger, M.D.

Internal Medicine · ROANOKE, VA · NPI 1497746887

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	626	155
Atorvastatin Calcium	Atorvastatin Calcium	539	146
Amlodipine Besylate	Amlodipine Besylate	477	128
Losartan Potassium	Losartan Potassium	329	82
Lisinopril	Lisinopril	303	83
Famotidine	Famotidine	223	68
Gabapentin	Gabapentin	219	70
Omeprazole	Omeprazole	199	56
Montelukast Sodium	Montelukast Sodium	198	65
Sertraline Hcl	Sertraline Hcl	197	48
Potassium Chloride	Potassium Chloride	193	58
Rosuvastatin Calcium	Rosuvastatin Calcium	193	56
Metoprolol Succinate	Metoprolol Succinate	174	49
Simvastatin	Simvastatin	174	45
Duloxetine Hcl	Duloxetine Hcl	145	42
Metoprolol Tartrate	Metoprolol Tartrate	141	37
Hydrochlorothiazide	Hydrochlorothiazide	133	45
Tamsulosin Hcl	Tamsulosin Hcl	126	30
Furosemide	Furosemide	122	42
Eliquis	Apixaban	120	25
Metformin Hcl	Metformin Hcl	120	35
Pantoprazole Sodium	Pantoprazole Sodium	114	32
Meloxicam	Meloxicam	112	34
Alendronate Sodium	Alendronate Sodium	102	40
Escitalopram Oxalate	Escitalopram Oxalate	100	33
Metformin Hcl Er	Metformin Hcl	97	26
Citalopram Hbr	Citalopram Hydrobromide	89	22
Buspirone Hcl	Buspirone Hcl	85	31
Trazodone Hcl	Trazodone Hcl	84	26
Alprazolam	Alprazolam	79	22
Mirtazapine	Mirtazapine	77	18
Carvedilol	Carvedilol	75	21
Glimepiride	Glimepiride	75	23
Memantine Hcl	Memantine Hcl	71	15
Diclofenac Sodium	Diclofenac Sodium	66	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	33
Ozempic	Semaglutide	65	15
Naproxen	Naproxen	64	35
Tramadol Hcl	Tramadol Hcl	64	26
Atenolol	Atenolol	63	17
Allopurinol	Allopurinol	58	16
Clopidogrel	Clopidogrel Bisulfate	56	14
Azithromycin	Azithromycin	55	50
Oxycodone Hcl	Oxycodone Hcl	53	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	52	14
Lorazepam	Lorazepam	51	12
Hydralazine Hcl	Hydralazine Hcl	50	14
Cefdinir	Cefdinir	49	40
Finasteride	Finasteride	48	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	48	12
Synthroid	Levothyroxine Sodium	47	13
Pravastatin Sodium	Pravastatin Sodium	46	17
Olmesartan Medoxomil	Olmesartan Medoxomil	45	14
Albuterol Sulfate Hfa	Albuterol Sulfate	42	22
Glipizide	Glipizide	41	13
Jardiance	Empagliflozin	41	12
Farxiga	Dapagliflozin Propanediol	40	12
Bumetanide	Bumetanide	38	suppressed
Clonidine Hcl	Clonidine Hcl	38	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	13
Carbidopa-Levodopa	Carbidopa/Levodopa	36	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	12
Baclofen	Baclofen	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	17
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	13
Olanzapine	Olanzapine	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Glipizide Er	Glipizide	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Meclizine Hcl	Meclizine Hcl	28	19
Spironolactone	Spironolactone	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	26
Amoxicillin	Amoxicillin	27	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Myrbetriq	Mirabegron	22	suppressed
Cephalexin	Cephalexin	21	18
Donepezil Hcl	Donepezil Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Doxycycline Hyclate	Doxycycline Hyclate	20	12
Estradiol	Estradiol	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	16
Clonazepam	Clonazepam	19	suppressed
Ramipril	Ramipril	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Gemfibrozil	Gemfibrozil	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Methylprednisolone	Methylprednisolone	17	17
Prazosin Hcl	Prazosin Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Diazepam	Diazepam	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Rivastigmine	Rivastigmine	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	11
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	15	15
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Humalog	Insulin Lispro	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Niacin Er	Niacin	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Invega Sustenna	Paliperidone Palmitate	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error